Patent Assignment
Reel/Frame 023679/0428
Notice of Grant of Security Interest in Patents
Recorded: 2009-12-22
Pages: 7
Assignor
PROMETHEUS LABORATORIES INC.
Executed: 2009-12-21
Assignee
BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
2001 CLAYTON DRIVE, MAIL CODE: CA4-702-02-25, CONCORD, CALIFORNIA, 94520-2405
Covered Properties
(58)
Lactam Derivatives
Patent:
5,183,820 →
Application:
07/691,814 →
Process for the Preparation of Lactam Derivatives
Patent:
5,196,534 →
Application:
07/704,099 →
Tetrahydro-1H-Pyrido[4,3-B]Indol-1-One Derivatives.
Patent:
5,360,800 →
Application:
07/741,570 →
5-HT3 Receptor Antagonists for the Treatment of Autism
Patent:
5,225,407 →
Application:
07/941,951 →
Process for the Preparation of Lactam Derivatives
Patent:
6,175,014 →
Application:
08/137,228 →
Methods of Diagnosing Clinical Subtypes of Crohn's Disease
Patent:
5,932,429 →
Application:
08/837,059 →
Methods of Diagnosing Clinical Subtypes of Crohn's Disease with Characteristic Responsiveness to Anti-TH1 Cytokine Therapy
Patent:
6,183,951 →
Application:
08/855,825 →
Inflammatory Bowel Disease First Step Assay System
Patent:
6,218,129 →
Application:
09/079,435 →
Medicaments for the Treatment of Non-Constipated Female Irritable Bowel Syndrome
Patent:
6,284,770 →
Application:
09/529,050 →
Method of Determining Thiopurine Methyltransferase Activity
Methods of Diagnosing Liver Fibrosis
Methods for Treating Irritable Bowel Syndrome
Methods of Quantifying Methotrexate Metabolites
Methods for Direct Detection of Individual Methotrexate Metabolites
Method of Determining Thiopurine Methyltransferase Acitivity
Methods of diagnosing liver fibrosis
Application:
10/504,544 →
Publication:
US 2006/0084057
Methods for Optimizing Clinical Responsiveness to Methotrexate Therapy Using Metabolite Profiling and Pharmacogenetics
Methods of Diagnosing Tissue Fibrosis
Methods of Diagnosing Inflammatory Bowel Disease
Methods for Predicting Methotrexate Polyglutamate Levels Using Pharmacogenetics
Method for optimizing thiopurine efficacy and toxicity using mass spectrometry
Application:
11/274,104 →
Publication:
US 2006/0216726
Methods of Predicting Methotrexate Efficacy and Toxicity
Application:
11/380,171 →
Publication:
US 2006/0286571
Methotrexate Compliance Packaging
Application:
11/555,216 →
Publication:
US 2007/0093497
Methods of Diagnosing Inflammatory Bowel Disease
Method and System for Assisting in Diagnosing Irritable Bowel Syndrome
Patent:
7,943,328 →
Application:
11/679,149 →
Methods of Predicting and Monitoring Tyrosine Kinase Inhibitor Therapy
Methods for Diagnosing Irritable Bowel Syndrome
Application:
11/838,810 →
Publication:
US 2008/0085524
Methods for Diagnosing Irritable Bowel Syndrome
Methods of Diagnosing Inflammatory Bowel Disease
Application:
11/841,699 →
Publication:
US 2008/0182280
Methods for Diagnosing Irritable Bowel Syndrome
Patent:
8,685,741 →
Application:
12/043,082 →
Antibody-Based Arrays for Detecting Multiple Signal Transducers in Rare Circulating Cells
Drug Selection for Lung Cancer Therapy Using Antibody-Based Arrays
Non-Thiopurine Methyltransferase Related Effects in 6-Mercaptopurine Therapy
Methods for Diagnosing Irritable Bowel Syndrome
Application:
12/253,177 →
Publication:
US 2010/0094560
Genes Involved in Intestinal Inflammatory Diseases and Use Thereof
Methods to Predict Risk for Celiac Disease by Detecting Anti-Flagellin Antibody Levels
Patent:
8,409,819 →
Application:
12/392,997 →
Method of Using Cytokine Assay to Diagnose, Treat, and Evaluate Inflammatory and Autoimmune Diseases
Application:
12/410,394 →
Publication:
US 2009/0325167
Addressable Antibody Arrays and Methods of Use
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Methods to Predict Risk and Severity for Celiac Disease
Application:
61/118,968 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/140,558 →
Citrullinated Peptides for Diagnosing and Prognosing Rheumatoid Arthritis
Application:
61/164,840 →
Methods of Inflammatory Bowel Disease Prognosis and Biological Response Prediction
Application:
61/169,230 →
Methods of Inflammatory Bowel Disease Prognosis and Biological Response Prediction
Application:
61/178,454 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/178,458 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/180,787 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/187,246 →
Methods to Predict Probability for Surgery in Crohn's Disease Patients
Application:
61/220,453 →
Methods for Diagnosing Irritable Bowel Syndrome
Application:
61/220,525 →
Drug Selection for Gastric Cancer Therapy Using Antibody-Based Arrays
Application:
61/225,866 →
Drug Selection for Breast Cancer Theapy Using Antibody-Based Arrays
Application:
61/228,522 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/235,646 →
Pathway Analysis for Herceptin Resistance
Application:
61/241,804 →
Diagnosis and Treatment of Early Onset Rheumatoid Arthritis
Application:
61/243,496 →
Methods for Diagnosing Irritable Bowel Syndrome
Application:
61/252,094 →
Proximity-Mediated Assays for Detecting Oncogenic Fusion Proteins
Application:
61/253,393 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/255,048 →
Methods to Predict Probability for Surgery in Crohn's Disease Patients
Application:
61/255,066 →
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 19, 2012
From: PROMETHEUS LABORATORIES INC.
To: NESTEC S.A.
Reel/Frame 029504/0740 →
Short-Form Patent Security Agreement
Oct 15, 2013
From: EXAGEN DIAGNOSTICS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031414/0660 →
Release of Security Interest
Dec 29, 2015
From: BANK OF AMERICA, N.A.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 037378/0464 →
Security Interest
Jan 4, 2016
From: SEBELA INTERNATIONAL 2 LIMITED, AS GRANTOR
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC (SUCCESSOR-IN-INTEREST TO GENERAL ELECTRIC CAPITAL CORPORATION), AS AGENT
Reel/Frame 037400/0440 →
Assignment of Assignor's Interest
Jan 13, 2016
From: PROMETHEUS LABORATORIES INC.
To: SEBELA INTERNATIONAL LIMITED
Reel/Frame 037471/0944 →
Confirmatory License
Jul 8, 2016
From: CEDARS-SINAI MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039292/0238 →
Release of Security Interest
Sep 1, 2017
From: CYPRESS BIOSCIENCE INC.
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 043747/0382 →
Release of Security Interest
Sep 7, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 043784/0828 →
Security Interest
Sep 11, 2017
From: EXAGEN DIAGNOSTICS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 043548/0228 →
Assignment of Assignor's Interest
Jun 26, 2018
From: SEBELA INTERNATIONAL LIMITED
To: SEBELA INTERNATIONAL BERMUDA LIMITED
Reel/Frame 046200/0934 →
Merger
Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
Corrective Assignment to Correct the English Translation to Show the Full and Correct New Name in Section 51. Previously Recorded at Reel: 049391 Frame: 0756. Assignor(S) Hereby Confirms the Merger.
Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
Assignment of Assignor's Interest
Jul 18, 2019
From: SEBELA INTERNATIONAL BERMUDA LIMITED
To: SEBELA IRELAND LIMITED
Reel/Frame 049791/0116 →
Merger
Aug 8, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049997/0344 →
Assignment of Assignor's Interest
Aug 26, 2019
From: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
To: PRECISION IBD, INC.
Reel/Frame 050166/0001 →
Change of Name
Oct 17, 2019
From: PRECISION IBD, INC.
To: PROMETHEUS BIOSCIENCES, INC.
Reel/Frame 050886/0942 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912.
Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912.
Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
Assignment of Assignor's Interest
Feb 8, 2021
From: PROMETHEUS BIOSCIENCES, INC.
To: PROMETHEUS LABORATORIES, INC.
Reel/Frame 055256/0976 →
Assignment of Assignor's Interest
Oct 7, 2021
From: PROMETHEUS BIOSCIENCES, INC.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 057730/0993 →
Assignment of Assignor's Interest
Nov 3, 2021
From: PROMETHEUS LABORATORIES INC.
To: EXAGEN INC.
Reel/Frame 058007/0978 →
Confirmatory License
Nov 16, 2023
From: CEDARS SINAI MEDICAL CENTER
To: NIH-DEITR
Reel/Frame 065611/0270 →
Security Interest
Apr 25, 2025
From: EXAGEN INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070952/0802 →
Release of Security Interest
Apr 25, 2025
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: EXAGEN INC.
Reel/Frame 070951/0040 →